China: In a significant clinical finding, researchers from The Second Affiliated Hospital of Anhui Medical University, China, ...

The Food and Drug Administration (FDA) has approved DefenCath ® (taurolidine and heparin) catheter lock solution to reduce the incidence of catheter-related bloodstream infections (CRBSI) in ...

Such catheters are usually considered temporary vascular access since they have a high risk of infection. Peritoneal dialysis catheter. To carry out peritoneal dialysis, surgeons use a long ...

DefenCath is intended for instillation into central venous catheters ... related bloodstream infections (CRBSI), in adult patients with kidney failure, receiving chronic hemodialysis through ...

Multifaceted quality improvement interventions may prevent hemodialysis catheter-related bloodstream infections outside the ICU, however, more research is needed, according to published data.

The method a dialysis provider used to access a patient’s cardiovascular system made the biggest difference in the risk of S. aureus infections, the data show. Central venous catheters ...

Hemodialysis patients are at high risk for infection because the process of hemodialysis requires frequent use of catheters or insertion of needles to access the bloodstream. • Hemodialysis ...

Methicillin is a penicillin antibiotic used to treat infections ... the presence of a long-term catheter such as a dialysis catheter, residence at a long-term care facility, or prolonged ...

Replacing the commonly used blood-thinner heparin with a clot-dissolving stroke drug in dialysis catheters once a week may reduce the incidence of catheter malfunctions and infections, according to ...

Catheter-related bloodstream infections (CRBSI ... especially kidney diseases, require hemodialysis, which further leads to the use of catheters in hospitalized patients. The catheters are ...